abs327.txt	purpose		to	identify	clinical	parameters	that	are	prognostic	for	improved	overallsurvival	(os)	after	yttrium-90	radioembolization	(re)	in	patients	with	livermetastases	from	colorectal	cancer	(crc)	materials	and	methods	a	total	of	131	who	underwent	re	crc	treated	at	2	academic	centers	were	reviewed	twenty-onebaseline	pretreatment	factors	analyzed	relation	os	by	thekaplan-meier	method	along	log-rank	tests	univariate	multivariate	coxregression	analyses	results	the	median	first	procedure	was	10	7	months	(95%	confidenceinterval	[ci]	9	4-12	months)	several	including	lowercarcinoembryonic	antigen	(cea	≤20	ng/ml)	lower	aspartate	transaminase	(ast	≤40iu/l)	neutrophil-lymphocyte	ratio	(nlr)	<5	absence	extrahepatic	diseaseat	baseline	associated	significantly	comparedwith	high	cea	(>20	ast	(>40	iu/l)	nlr	≥5	extrahepaticmetastases	(p	values	<	001	0001	04	respectively)	onmultivariate	analysis	higher	disease	andlarger	volume	liver	metastases	remained	independently	risk	ofdeath	(hazard	ratios	1	63	06	22	48	02	conclusions	prognosis	is	impacted	acomplex	set	this	factorsidentified	tumor	burden	(intra-	orextrahepatic)	be	survival	hepaticre	optimal	selection	may	improve	survivalrates	administration
